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Abstract
Background: Acute lung injury (ALI) is a major component of multiple organ dysfunction syndrome (MODS)
following pulmonary and systemic infection. Alveolar macrophages (AMϕ) are at the center of ALI pathogenesis.
Emerging evidence has shown that cell-cell interactions in the lungs play an important regulatory role in the
development of acute lung inflammation. However, the underneath mechanisms remain poorly addressed. In this
study, we explore a novel function of lung epithelial cells (LEPCs) in regulating the release of exosomes from AMϕ
following LPS stimulation.
Methods: For the in vivo experiments, C57BL/6 wildtype (WT) mice were treated with lipopolysaccharide (LPS)
(2 mg/kg B.W.) in 0.2 ml of saline via intratracheal aerosol administration. Bronchoalveolar lavage fluid was collected
at 0–24 h after LPS treatment, and exosomes derived from AMϕ were measured. For the in vitro studies, LEPCs and
bone marrow-derived Mϕ (BMDM) were isolated from WT or TLR4−/− mice and were then cocultured in the
Transwell™ system. After coculture for 0–24 h, the BMDM and supernatant were harvested for the measurement of
exosomes and cytokines.
Results: We demonstrate that LPS induces macrophages (Mϕ) to release exosomes, which are then internalized by
neighboring Mϕ to promote TNF-α expression. The secreted interleukin (IL)-25 from LEPCs downregulates Rab27a
and Rab27b expression in Mϕ, resulting in suppressed exosome release and thereby attenuating exosome-induced
TNF-α expression and secretion.
Conclusion: These findings reveal a previously unidentified crosstalk pathway between LEPCs and Mϕ that
negatively regulates the inflammatory responses of Mϕ to LPS. Modulating IL-25 signaling and targeting exosome
release may present a new therapeutic strategy for the treatment of ALI.
Keywords: Acute lung injury, Sepsis, Multiple organ failure, Rab27

Background
Acute lung injury (ALI) is a major component of multiple
organ dysfunction syndrome (MODS) following sepsis [1, 2].
However, information about the factors that predispose septic patients to MODS or ALI remains poor, and this paucity
of knowledge contributes to high mortality rates and a lack
of effective treatments [2–4]. Emerging evidence suggests an
important role for cell-cell interaction in the regulation of
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ALI progression [5–7]. For instance, we have reported a role
for hemorrhagic shock-activated polymorphonuclear neutrophils (PMN) that have migrated to the lung in counteracting
the effects of anti-inflammatory NOD2-induced autophagy
of alveolar macrophages (AMϕ) [6]. The current study investigates important interactions between lung epithelial cells
(LEPCs) and AMϕ.
Residential AMϕ serve as the front line of cellular
defense in the recognition and clearance of pathogens
[8, 9]. AMϕ are also at the center of ALI pathogenesis
through their secretion of cytokines and chemokines that
regulate lung inflammation in response to pulmonary
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infection [8]. A recent study from our laboratory showed
that exosomes released from hemorrhagic shock-activated
AMϕ induced the production of NADPH oxidase-derived
reactive oxygen species (ROS) inside PMN, resulting
in necroptosis and subsequently enhancing lung inflammation [7].
Exosomes are extracellular vesicles (EVs) with lipid bilayer membranes, and they range in size from 30 to
100 nm. Exosomes are formed as intraluminal vesicles
(ILVs) by budding into early endosomes to form multivesicular bodies (MVBs) and can contain miRNA, proteins,
and lipids [10]. The biogenesis of ILVs involves endosomal sorting complexes required for transport (ESCRT)
machinery, lipids and tetraspanins. The transport of
MVBs to the plasma membrane is a critical step for exosome secretion [11, 12] and involves important roles for
Rab proteins, such as Rab11, Rab27 and Rab35 [13–15].
Studies have indicated that Rab27a and Rab27b control the steps that the vesicles undergo during docking to their target compartment, which leads to
vesicular fusion with the plasma membrane and the
subsequent secretion of CD63-containing exosomes [14].
Alveolar epithelial cells form a barrier serving as
the first line of pathogen defense in the alveolus, and
they are essential for maintaining lung respiratory
function [16]. The alveolar epithelium comprises two
main cell types: alveolar type I cells and alveolar type
II cells. Type I cells mainly form the gas exchange
surface in the alveolus, whereas type II cells have
many important metabolic and biosynthetic functions,
including the synthesis and secretion of the surfactant, which is a lipid-protein complex. Alveolar type
II cells are also considered to be progenitors of the
alveolar epithelium because of their ability to both
proliferate and differentiate into alveolar type I cells.
Recent studies have recognized important roles for type II
cell-derived cytokines, including interleukin (IL)-25, IL-33,
and thymic stromal lymphopoietin (TSLP), in the regulation of lung inflammation [17, 18].
In this study, we explore a novel function of LEPCs
in regulating the release of exosomes from AMϕ following LPS stimulation. We demonstrate that LPS induces macrophages (Mϕ) to release exosomes, which
are internalized by neighboring Mϕ to promote
TNF-α expression. The secreted IL-25 by LEPCs
downregulates Rab27a and Rab27b expression in Mϕ,
thereby suppressing both exosome release from Mϕ
and TNF-α expression and secretion. These findings
reveal a previously unidentified crosstalk pathway between LEPCs and Mϕ that negatively regulates the inflammatory responses of Mϕ to LPS. Modulating
IL-25 signaling and targeting exosome release may
present a new therapeutic strategy for the treatment
of ALI.
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Methods
Animal strains

Eight-week-old C57BL/6 wildtype (WT) male mice were
purchased from The Jackson Laboratory (Bar Harbor,
ME, USA). TLR4 knockout (TLR4−/−) mice were bred in
Dr. Billiar’s laboratory at the University of Pittsburgh.
All animal experimental protocols were reviewed and
approved by the Institutional Animal Care and Use
Committees of the University of Pittsburgh and the VA
Pittsburgh Healthcare System. The mice were given food
and water ad libitum.
Exosome isolation and characterization

Exosomes were isolated from culture supernatants of
bone marrow-derived macrophages (BMDM) maintained
in serum-free DMEM with 1% penicillin/streptomycin.
Supernatants from cultured BMDM were collected and
centrifuged at 2000 g for 30 min to remove debris,
followed by the addition of Total Exosome Isolation Reagent (ThermoFisher Scientific, Pittsburgh, PA) and incubation at 4 °C overnight following the manufacturer’s
instructions. The mixture was centrifuged at 10,000 g
for 60 min at 4 °C. The final pellet containing the exosomes was resuspended in PBS. To detect exosome
marker proteins, 100 μl of exosomes isolated from
medium or BALF were incubated with 10 μl of aldehyde/sulfate latex beads (4 μm diameter, Life Technologies, Grand Island, NY) for 15 min at 4 °C. PBS was
then added to the exosomes to increase the total volume
to 400 μl, followed by overnight incubation at 4 °C with
gentle agitation. The exosome-coated beads were stained
with PE-conjugated anti-mouse CD63 antibody for 1 h
at room temperature and were analyzed by flow
cytometry.
BMDM isolation and culture

BMDM were cultured as in our previous studies
[19, 20]. Briefly, bone marrow from femurs and tibias harvested from mice was flushed with prechilled
DMEM. The cell pellets were collected, and the erythrocytes were lysed with RBC lysis buffer. The resulting cells
were suspended in BMDM culture medium (DMEM containing 10% FBS supplemented with 50 μg/ml penicillin/
streptomycin and 10 ng/ml recombinant macrophage
colony-stimulating factor [M-CSF; Thermo Fisher Scientific]) at a concentration of 1 × 106 cells/ml and seeded
into 6-well plates. The culture medium for BMDM was
changed on day 3 and day 5. The BMDM were fully differentiated and ready for use on day 7.
Mouse LEPC isolation

Mice were euthanized with an overdose of pentobarbital
(50 mg/kg BW). The lungs were perfused with 10 ml
PBS through the right ventricle of the heart, and the
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lung tissue was then diced into pieces of approximately
1 mm3 for digestion in 5 ml of digestion medium containing DMEM/F12 with collagenase/dispase for 30–
45 min at 37 °C with vortexing every 10 min. The resulting samples were homogenized with 70 μm cell strainers,
and the cell pellet was then collected and treated with
DNase I (1 μg/ml) for 10 min. The remaining red blood
cells were lysed with RBC lysis buffer (Life Technologies
Corporation, Grand Island, NY) The cells were labeled
with biotin-conjugated anti-mouse CD326 antibody and
then incubated with streptavidin-conjugated immunomagnetic beads for 1 h at 4 °C. The CD326-positive epithelial
cells were selected by flow cytometry and cultured in
DMEM/F12 supplemented with 10% FBS and 50 μg/ml
penicillin/streptomycin.
LEPC and BMDM coculture

LEPCs and BMDM were cocultured using the Transwell™
system. LEPCs (1 × 106 cells per well) were seeded in the
6-well Transwell™ inserts, and BMDM (1 × 106 cells per
well) were seeded in the 6-well plates. After coculture, the
supernatant was harvested for further analysis.
Intratracheal injection of LPS in mice

Mice were anesthetized with ketamine (50 mg/kg B.W.)
combined with xylazine (5 mg/kg B.W.). LPS (2 mg/kg
B.W.) in 0.2 ml of saline was delivered via intratracheal
aerosol administration using a MicroSprayer® aerosolizer
high-pressure syringe (Penn-Century, Wyndmoor, USA).
The sham animals underwent the same anesthetic procedure and the intratracheal aerosol injection of 0.2 ml
of saline. Bronchoalveolar lavage fluid (BALF) was collected, and the AMϕ were isolated for further analysis.
Flow cytometry

BMDM-derived exosomes bound to aldehyde/sulfate latex
beads were stained with PE-CD63 (exosome maker) or
PE-isotype control antibody, followed by analysis with a
BD FACS flow cytometer. Control and LPS-treated
BMDM or AMϕ were stained with PE-IL25R or
PE-isotype control antibody followed by flow cytometric
analysis. The mean fluorescence intensity (MFI) was calculated by FlowJo v10.0.
Confocal immunofluorescence

Exosomes were isolated from the supernatant of control
or LPS-treated BMDM and stained with DiI cell-labeling
solution at 37 °C for 20 min. The DiI-labeled exosomes
were incubated with BMDM at 37 °C for 2 h. The cells
were fixed with 4% paraformaldehyde for 15 min at
room temperature. The nuclei were counterstained with
Hoechst 33,258. Fluorescence images were captured by
confocal microscopy.
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Western blotting

BMDM lysates were separated by 12% SDS-PAGE and
transferred onto PVDF membranes. After incubation for
1 h at room temperature with blocking buffer (LI-COR
Biosciences, Lincoln, NE, USA), blots were incubated
with a primary antibody (Rab27a, Rab27b, or GAPDH)
at 4 °C overnight followed by incubation with an appropriate secondary antibody (LI-COR Biosciences) for 1 h
at room temperature. Protein bands were detected using
the Odyssey system from LI-COR Biosciences and were
quantified using Image J version 1.50i.
RNA extraction and quantitative real-time PCR

The plated cells were harvested, and total RNA was isolated using TRIzol® RNA isolation reagents (Thermo
Fisher Scientific, Pittsburgh, PA, USA) following the
manufacturer’s instructions. Reverse transcription was
performed using iScript™ Reverse Transcription Supermix
(170–8840, Bio-Rad) following the manufacturer’s instructions. Real-time RT-PCR was performed using iTaq™ Universal SYBR® Green Supermix (1,725,121, Bio-Rad) in a
Bio-Rad iQ5 real-time PCR system (Bio-Rad). The following gene-specific primers were used for gene amplification: TNFa forward, 5’-GACGTGGAACTGGCAGAA
G-3′ and reverse, 5′-TTGGTGGTTTGTGAGTGTG-3′;
IL6 forward, 5’-CCAAGAGGTGAGTGCTTCCC-3′ and
reverse, 5’-CTGTTGTTCAGACTCTCTCCCT-3′; and
18S forward, 5’-GTAACCCGTTGAACCCCATT-3′ and
reverse, 5’-CCATCCAATCGGTAGTAGCG-3′. Amplification was performed with cycling conditions of 15 s at
95 °C followed by 30 s at 60 °C for 40 cycles. After the
amplification protocol was completed, the PCR product
was subjected to melting curve analysis using the Bio-Rad
iQ5 software (Bio-Rad). The fold change was calculated
using the ΔΔ threshold cycle method, and the value for
the 18S rRNA gene was used to normalize the gene expression in the experimental groups to that in the untreated groups.
Reagents

PE-conjugated anti-mouse CD63 antibody (143903);
PE-conjugated rat IgG2a, κ isotype ctrl antibody (400507);
anti-mouse IL-25 (IL-17E) antibody (514403); and purified
Rat IgG1, κ Isotype control antibody (400413) were from
Biolegend (San Diego, CA, USA). Exosome-releasing inhibitor DMA (sc-202,459) was purchased from Santa Cruz
(Dallas, TX, USA). LPS (L2880), and polymyxin B-agarose
(P1411) and DNase I (11284932001) were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Recombinant mouse
IL-17E (IL-25) protein (1399-IL-025), recombinant mouse
IL-33 protein (3632-ML), and recombinant mouse TSLP
protein (555-TS) were purchased from R&D Systems. The
IL-25 mouse ELISA kit (88–7002-22), TNF alpha mouse
ELISA kit (88–7324-86), DiI cell-labeling solutions
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(V22885), total exosome isolation reagent (4478359),
PE-IL-25R (IL-17RB) monoclonal antibody (MUNC33)
(12–7361-80), PE-Cyanine7 CD326 (EpCAM) monoclonal
antibody (1B7), biotin-conjugated CD326 (13–5791-82),
and aldehyde/sulfate latex beads (4% w/v, 4 μm diameter,
A37304) were purchased from Thermo Fisher Scientific
(Pittsburgh, PA, USA). Anti-Rab27a (69295S) and
anti-GAPDH (5174S) antibody were from Cell Signaling
Technology (Danvers, MA, USA). Anti-Rab27b (ABS1026)
was from MilliporeSigma (Kankakee, IL, USA). The siNC,
siRab27a, and siRab27b RNAs were purchased from Integrated DNA Technologies (Coralville, IA, USA). BD IMag™
Streptavidin Particles Plus were purchased from BD Biosciences (San Jose, CA, USA).
Statistical analysis

The data are presented as the mean ± SEM of the indicated number of experiments/repeats. SPSS 20.0 or
GraphPad Prism v.6.0 was used for statistical analysis.
Significance differences between groups were determined by one-way ANOVA, two-way ANOVA, or independent sample two-tailed Student’s t-test, and P < 0.05
was considered statistically significant.

Results
LEPCs suppress the LPS-induced release of exosomes
from Mϕ

BMDM were cultured without serum for 24 h, and exosomes released from BMDM were isolated and identified
by staining with the exosome marker CD63 and analysis
by flow cytometry as shown in Fig. 1a. In addition, nanoparticle tracking analysis using NanoSight was used to
determine the diameter and number of the extracellular
particles in the culture media of BMDM with or without
24 h of LPS treatment. The diameter of the extracellular
particles in both groups was in the range of ~ 100 nm
(Fig. 1b), suggesting that the particles were exosomes;
however, the total number of extracellular vesicles in the
LPS-treated group was significantly increased (Fig. 1b).
LPS treatment of BMDM for up to 24 h significantly
increased the release of exosomes from Mϕ in a
time-dependent manner (Fig. 1c), and pretreatment of
BMDM with the exosome release inhibitor dimethyl
amiloride (DMA, 25 μg/ml) [21] prevented the
LPS-induced release of exosomes (Fig. 1d).
To study the interaction between lung epithelial cells
(LEPCs) and macrophages, CD326-positive LEPCs, which
are mainly type II epithelial cells [22, 23], were isolated
from mouse lung tissue using magnetic-activated cell sorting (MACS) [22, 24] and confirmed by flow cytometry
(Fig. 1e). The results showed that the selection of CD326+
LEPCs reached a purity of > 95%. We further cocultured
LEPCs with BMDM using Transwell plates and treated
the cultures with LPS for 24 h. Interestingly, the exosome
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release from monocultured LEPCs was very low in both
the LPS-treated and non-LPS-treated conditions (Fig. 1f).
We also found that the exosome release in response to
LPS in the cocultured group was significantly decreased
compared with that in the BMDM monoculture group
(Fig. 1f). These results suggest that the release of
macrophage-derived exosomes is suppressed by LEPCs.
IL-25 mediates LEPC suppression of macrophage-derived
exosome release

LEPCs release innate cytokines, such as TSLP, IL-33,
and IL-25, in response to infection or various environmental factors [17, 18, 25]. To determine whether the
suppression of macrophage-derived exosome release by
LEPCs is mediated through epithelial cytokines, we
treated BMDM with LPS and recombinant TSLP, IL-25,
or IL-33 for 24 h. As shown in Fig. 2a, recombinant
IL-25 exhibited a significant suppressive effect on the
LPS-induced release of exosomes from BMDM, whereas
TSLP and IL-33 did not significantly affect exosome release. Furthermore, compared to the addition of
non-specific IgG, the addition of anti-IL-25 neutralizing
antibody to the LPS-treated LEPC-BMDM coculture
system partially restored the release of exosomes from
BMDM (Fig. 2b).
To confirm whether IL-25 was secreted from LEPCs
in response to LPS, we measured IL-25 mRNA expression in LEPCs and IL-25 concentration in the
culture supernatant following LPS treatment for up to
24 h. As shown in Fig. 2c, IL-25 mRNA expression
increased in LEPCs following LPS treatment and
reached a peak at 12 h after LPS treatment. The
IL-25 protein concentration in the culture supernatant
of LEPCs also increased and reached a peak at 24 h
after LPS treatment (Fig. 2d). We further found that
IL-25 receptor (IL-25R) expression in BMDM increased in response to LPS treatment (Fig. 2e). These
results suggest enhanced IL-25-induced signaling in
macrophages.
IL-25 downregulates LPS-induced Rab27a and Rab27b
expression in Mϕ and suppresses exosome release

The Ras-related proteins Rab27a and Rab27b have
been reported to play a role in multivesicular endosome docking at the plasma membrane; and are
therefore important in regulating exosome secretion
[11, 14]. To elucidate whether LEPC-derived IL-25 affects Rab27a and Rab27b to suppress exosome release
from macrophages, we first measured Rab27a and
Rab27b expression in BMDM following LPS treatment. The expression of both Rab27a and Rab27b increased in BMDM starting at 12 h after LPS stimulation
(Fig. 3b), and coincubation with LEPCs or treatment with
IL-25 markedly decreased Rab27a and Rab27b expression
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Fig. 1 LEPCs suppress LPS-induced exosome release from Mϕ. a Exosomes were isolated from BMDM cultured in serum-free medium, stained
with PE-isotype and PE-CD63 antibodies and measured by flow cytometry. b Exosomes isolated from the culture media of control and LPStreated BMDM were analyzed for the mean particle diameter and total number by NanoSight. c BMDM were treated with LPS (1 μg/ml) for 0, 6,
12, and 24 h. Exosomes were then isolated from the culture medium and detected by CD63 staining and flow cytometry. d BMDM were treated
with LPS (1 μg/ml) in the presence or absence of dimethyl amiloride (DMA, 25 μM) for 24 h. Exosomes were then isolated from the culture
medium and detected by CD63 staining and flow cytometry. e Lung cells were labeled with biotin-conjugated CD326 antibody and separated
with streptavidin-conjugated immunomagnetic beads. Flow cytometric analysis shows a purity of greater than 95% for the yielded LEPCs. f
BMDM were cultured alone or cocultured with LEPCs and were either treated with LPS (1 μg/ml) for 24 h or not treated. Exosomes were isolated
from the culture medium and detected by CD63 staining and flow cytometry. All results are representative of at least three independent
experiments. The graphs show the mean ± SEM, n = 3; *P < 0.05 or **P < 0.01, compared with the indicated groups

in BMDM at 12 h after LPS treatment (Fig. 3c). Furthermore, siRNA knockdown of Rab27a and Rab27b in
BMDM significantly decreased exosome release from the
macrophages in response to LPS stimulation (Fig. 3a).
These data suggest that IL-25 downregulates LPS-induced
Rab27a and Rab27b expression to suppress exosome release from macrophages.

Suppression of exosome release from Mϕ attenuates
TNFα secretion by Mϕ

To investigate the influence of suppressed exosome release on the development of inflammation, we measured
alterations in the expression of TNF-α and IL-6 mRNA
and protein in BMDM. As shown in Fig. 4a and b, coculture of LEPCs and BMDM resulted in significantly
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Fig. 2 IL-25 mediates LEPC-mediated suppression of exosome release from Mϕ. a BMDM were treated with LPS (1 μg/ml) with or without
recombinant IL-25 (200 ng/ml), IL-33 (200 ng/ml), or TSLP (200 ng/ml) for 24 h followed by isolation of exosomes from the cell culture supernatants,
and CD63+ exosomes were identified by flow cytometry. b BMDM cultured alone or cocultured with LEPCs were treated with LPS (1 μg/ml) in the
presence or absence of anti-IL-25 neutralizing antibody (10 μg/ml) or control non-specific IgG (10 μg/ml). CD63+ exosomes were detected by flow
cytometry. c and d LEPCs were treated with LPS (1 μg/ml) for 0, 6, 12, or 24 h, and the IL-25 mRNA expression in the LEPCs and IL-25 protein
concentration in the supernatants were measured by RT-qPCR (c) and ELISA (d), respectively. e BMDM were treated with LPS (1 μg/ml) for 24 h, and
the cell surface expression of IL-25R was measured by flow cytometry. All results are representative of three independent experiments. The graphs
show the mean ± SEM, n = 3; *P < 0.05 or **P < 0.01, compared with the indicated groups or with the control

decreased levels of TNF-α mRNA and protein in BMDM
at 24 h after LPS treatment. However, the IL-6 mRNA
and protein levels in these BMDM did not change significantly. This observation led us to hypothesize that
macrophage-derived exosomes may augment the expression of TNF-α in macrophages through autocrine or

paracrine mechanisms. To test this hypothesis, we
blocked exosome release using DMA to inhibit exosome
release-related signaling. As shown in Fig. 4c, the blockade of exosome release from Mϕ significantly decreased
the expression of TNF-α but not of IL-6 in Mϕ at 24 h
after LPS treatment. Pretreatment with recombinant
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Fig. 3 IL-25 downregulates LPS-induced Rab27a and Rab27b to suppress exosome release from macrophages. a BMDM were transfected with
siRab27a, siRab27b, or siNC (control) for 36 h and were then treated with LPS (1 μg/ml) for 24 h. Exosomes were isolated from the culture media,
and CD63 staining was detected by flow cytometry. b BMDM were treated with LPS (1 μg/ml) for 0, 6, 12, and 24 h. Rab27a and Rab27b
expression were detected by Western blotting. c BMDM cultured alone or cocultured with LEPCs were treated with LPS (1 μg/ml) in the presence
or absence of recombinant IL-25 (200 ng/ml) for 24 h. The expression of Rab27a and Rab27b were detected by Western blotting. All results are
representative of three independent experiments. The graphs show the mean ± SEM, n = 3; * or # P < 0.05, ** or ## P < 0.01, compared with the
LPS groups. * and ** indicate Rab27a, # and ## indicate Rab27b

IL-25, which, as we showed above, suppressed exosome
release from Mϕ, decreased LPS-induced TNF-α expression in Mϕ. Conversely, treatment with anti-IL-25 neutralizing antibody reversed the suppression of TNF-α
expression in BMDM cocultured with LEPCs (Fig. 4d).
To determine whether exosomes derived from Mϕ are
able to enter or reenter macrophages, we isolated exosomes from the culture supernatants of control and
LPS-treated BMDM and labeled them with DiI. We then
added the labeled exosomes to unstimulated BMDM for
2 h and assessed internalization by confocal immunofluorescence. We observed internalization of exosomes
from both unstimulated and LPS-stimulated Mϕ in the
culture of BMDM (Fig. 4e). However, significantly more
exosomes from LPS-treated Mϕ were internalized compared to the number of internalized exosomes from unstimulated Mϕ (Fig. 4e).
To address whether LPS in exosomes contributes to
exosome-stimulated increases in TNF-α expression in
Mϕ, we isolated exosomes from the culture supernatants
of control and LPS-treated BMDM and treated them
with polymyxin B (PMB), which binds the lipid A moiety
of LPS and neutralizes the biological effects of LPS [26].

We then treated BMDM isolated from WT and TLR4−/−
mice with the control and LPS-treated exosomes +/−
PMB for 6 h. As shown in Fig. 4f, PMB-treated exosomes from LPS-induced BMDM significantly increased
TNF-α expression in WT and TLR4−/− BMDM. These
results suggest that components of LPS-induced exosomes but not the contaminating LPS are responsible
for increasing TNF-α expression in Mϕ. .
IL-25 suppresses AMϕ exosome release in vivo

To recapitulate the in vitro study in vivo, we treated WT
mice with intratracheal (i.t.) injections of LPS to induce
acute lung injury. At 24 h after i.t. LPS administration,
the IL-25 concentration in the bronchoalveolar lavage
fluid (BALF) was significantly increased compared to the
concentration in the BALF of sham mice (Fig. 5a). The
IL-25R surface expression on AMϕ was also markedly
increased in LPS-treated mice compared to sham mice
(Fig. 5b). Notably, anti-IL-25 neutralizing antibody increased exosome release in response to i.t. LPS (Fig. 5c).
Collectively, these results suggest an important role for
LEPC-derived IL-25 in suppressing the secretion of exosomes from AM in response to LPS.
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Fig. 4 Suppression of exosome release from Mϕ attenuates the secretion of TNFα from Mϕ. a and b BMDM cultured alone or cocultured with LEPCs
were treated with LPS (1 μg/ml) for 24 h. Then, TNF-α and IL-6 mRNA levels in the BMDM and protein levels in the supernatants were measured by
RT-qPCR and ELISA, respectively. c BMDM were treated with LPS (1 μg/ml) with or without dimethyl amiloride (DMA, 25 μmol/L) for 24 h, and then the
TNF-α and IL-6 levels in the supernatants were measured by ELISA. d BMDM cultured alone or cocultured with LEPCs were treated with LPS (1 μg/ml)
in the presence or absence of recombinant IL-25 (200 ng/ml), anti-IL-25 neutralizing antibody (10 μg/ml), or non-specific IgG (10 μg/ml) for 24 h. The
level of TNF-α in the supernatants was measured by ELISA. e Immunofluorescence images show Mϕ internalization of exosomes. BMDM were
incubated with DiI-labeled exosomes (red) that were isolated from the culture media of untreated or LPS-treated BMDM (1 μl/ml) for 2 h. Nuclei were
counterstained with Hoechst (blue). The fold changes in DiI fluorescence intensity were calculated by ImageJ. f Exosomes were isolated from the
culture media of untreated or LPS-treated BMDM (1 μl/ml) for 24 h and were then added to WT or TLR4−/− BMDM and incubated for 6 h. The level of
TNF-α in the supernatants was measured by ELISA. All results are representative of three independent experiments. Three random fields in the images
were counted. The graphs show the mean ± SEM, n = 3; *P < 0.05 or **P < 0.01, compared with the indicated groups or with the control. NS, no
significant difference

Discussion
ALI is a common and severe complication following pulmonary infection [27]. The activation of innate immunity is critically involved in the progression of ALI. In this
study, we identified a novel mechanism by which LEPCs
negatively regulate exosome release from Mϕ through
IL-25 in response to the bacterial product LPS. Our results show that LEPC-derived IL-25 downregulates
Rab27a and Rab27b expression in Mϕ and subsequently
suppresses exosome release from Mϕ and attenuates

exosome-induced TNF-α expression and secretion from
Mϕ.
Our previous studies revealed roles for cell-cell interactions between multiple cell types in the progression of
ALI. We have shown that interactions between PMN
and endothelial cells contribute to the enhanced expression of ICAM-1 on endothelial cells and subsequently
augment the adhesion and transmembrane migration of
PMN into infected lungs [28]. We also found that AMϕ
are a major regulatory cell population that can actively

Li et al. Military Medical Research (2018) 5:24

Page 9 of 11

Fig. 5 IL-25 suppresses exosome release from AMϕ in vivo. a and b WT mice were given intratracheal (i.t.) LPS (2 mg/kg BW in a volume of
100 μl/mouse) or sham (i.t. PBS, 100 μl/mouse) for 24 h, and BALF was collected. IL-25 was measured in the supernatant by ELISA (a) and the
surface expression of IL-25R on AMϕ was detected by flow cytometry (b). c WT mice were treated with LPS (2 mg/kg BW in a volume of 100 μl/
mouse, i.t.), sham (PBS, 100 μl/mouse, i.t.), LPS (2 mg/kg BW, i.t.) + IgG (1 mg/kg BW, i.t.); or LPS (2 mg/kg BW, i.t.) + anti-IL-25 antibody (1 mg/kg
BW, i.t.) for 24 h. Exosomes were isolated from BALF and quantified by CD63 staining and flow cytometry. All results are representative of three
independent experiments. The graphs show the mean ± SEM, n = 3; *P < 0.05 or **P < 0.01, compared with the indicated groups or with
the control

influence the function of other cell populations. For example, we reported that chemokines derived from AMϕ
are a determinant of the migration of PMN through the
regulation of G-protein coupled receptor kinase expression in PMN and the surface expression of chemokine
receptors on PMN [7, 29]. Our recent study showed that
exosomes released from AMϕ act as an important mediator to induce necroptosis of PMN and enhance lung inflammation following hemorrhagic shock [7]. The
current study provides further evidence to support important roles for cell-cell interactions in the regulation
of lung inflammation. More importantly, this study
shows that the function of AMϕ can also be regulated
by other cell populations such as LEPCs.
The results demonstrate an important role for
LEPC-derived IL-25 in regulating the release of exosomes from macrophages. We were unable to detect
IL-25 in supernatants from BMDM after LPS stimulation. However, the sensitivity of the ELISA is a

limitation, and we may not be able to exclude the possibility that BMDM release IL-25 in response to LPS.
Nonetheless, the data shown in Fig. 2a, b, c and d support the conclusion that LEPCs are the major source of
IL-25 that affects the release of exosomes from macrophages. Notably, as shown in Fig. 2b, exosome release
from LPS-stimulated BMDM did not return to its peak
level after IL-25 was blocked with a neutralizing antibody in the co-culture of LEPCs with BMDM. We are
aware that the binding of antibody to antigen follows the
rule of binding dynamics involving a disassociation constant, and the achievement of > 90% antigen inhibition
requires a very high concentration of the neutralizing
antibody. Therefore, we believe that the antibody concentration used in the experiments may not have
reached a level that was able to completely abolish the
effects of IL-25; thus, the MFI of the “BMDM +LEPC
+LPS + IL25Ab” group did not exhibit 100% restoration.
However, the difference in MFI between the “BMDM

Li et al. Military Medical Research (2018) 5:24

+LEPC+LPS + IgG” and “BMDM+LEPC+LPS + IL25Ab”
groups (Fig. 2b) should clearly reflect the role of IL-25
in suppressing exosome release from BMDM.
Exosome secretion requires the fusion of multivesicular bodies (MVBs) with the cell plasma membrane.
The Rab GTPases critically regulate the multiple steps
of membrane trafficking, including vesicle budding,
vesicle transport, and membrane fusion. It has been
reported that knockdown of Rab family members, including Rab2b, Rab5a, Rab9a, Rab27a, or Rab27b, significantly decreases exosome secretion [30, 31].
Rab27a and Rab27b have been reported as important
regulatory factors governing intracellular vesicular
trafficking critical for MVB docking to the plasma
membrane [14]. In this study, we also demonstrated
an important role for Rab27a and Rab27b in the
regulation of the release of exosomes from Mϕ. This
role is evidenced by the following observations: 1)
Mϕ Rab27a and Rab27b expression increased in response to LPS; 2) knockdown of Rab27a or Rab27b
significantly decreased exosome release from Mϕ; and
3) downregulation of LPS-induced Rab27a and
Rab27b expression by IL-25 suppressed exosome release from Mϕ. Interestingly, our study identifies a
novel role for IL-25 in downregulating the expression
of Rab27a and Rab27b in Mϕ, although the mechanism underlying the IL-25-mediated regulation of
Rab27a and Rab27b expression is unknown, and future studies will be needed to elucidate the signaling
process and mechanism.
Cytokines, chemokines and cell surface receptors
are well known to mediate intercellular communication. Emerging evidence suggests that exosomes also
serve as important mediators of cell-cell interaction
[7]. Exosomes carry a variety of different molecules
that can be taken up by recipient cells [32]. In this
study, we found that exosomes derived from Mϕ are
important mediators that promote the expression of
TNF-α in Mϕ. By tracking exosomes with DiI staining, we
observed that extracellular exosomes were internalized by
Mϕ, which further promoted the expression of TNF-α but
not of IL-6. These results suggest a specific pathway mediating exosome-induced TNF-α expression, although at
present, it is not clear which exosome component is responsible. LPS contamination of exosomes does not appear to be the main stimulator, since neither PMB
treatment of exosomes nor TLR4 knockout in Mϕ reduced exosome-induced TNF-α expression.
In summary, our study demonstrates a novel mechanism underlying the crosstalk between LEPCs and Mϕ
and its potential role in the regulation of ALI. Modulating IL-25 signaling and targeting exosome release
may present new therapeutic strategies for the treatment of ALI.
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Conclusions
This study demonstrates that LPS induces macrophages
(Mϕ) to release exosomes, which are then internalized
by neighboring Mϕ to promote TNF-α expression. The
IL-25 secreted from LEPCs downregulates Rab27a and
Rab27b expression in Mϕ, resulting in suppressed exosome release and thereby attenuating exosome-induced
TNF-α expression and secretion. These findings reveal a
previously unidentified pathway of crosstalk between
LEPCs and Mϕ that negatively regulates inflammatory
responses of Mϕ to LPS. Modulating IL-25 signaling and
targeting exosome release may present a new therapeutic
strategy for the treatment of ALI.
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